Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis

Transplant Proc. 2000 Nov;32(7):1714-5. doi: 10.1016/s0041-1345(00)01403-2.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Azathioprine / therapeutic use
  • Cadaver
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Kidney Transplantation / physiology
  • Kidney Tubular Necrosis, Acute / pathology*
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Tissue Donors

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine
  • Prednisone
  • Tacrolimus